Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
McCormack, P
CT-388 is an orally or injectably administered dual GLP-1R and GIPR agonist that is in the early stages of development
Oral options may be a good fit if: Youve reached your goal and want to taper off injections You want to avoid needles or prefer a simpler starting point Your insurance covers oral medications over injections You prefer a daily routine instead of weekly dosing Youre paying out of pocket and want a more affordable option You dont have diabetes Youre aiming to lose less than 15% of your body weight Who Should Stick With Injections
This can lead to more serious problems - insulin resistance and water retention can occur
Important UK patient notice: Tirzepatide is only available in the UK as pre-filled pens (Mounjaro for diabetes and Zepbound for weight management)
